Related Experiment Video
Updated: Oct 3, 2025

Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
Heparin-Functionalized Adsorbents Eliminate Central Effectors of Immunothrombosis, including Platelet Factor 4,
Marie Ebeyer-Masotta1, Tanja Eichhorn1, René Weiss1
1Center for Biomedical Technology, Department for Biomedical Research, Danube University Krems, 3500 Krems, Austria.
Insights
Heparin-functionalized adsorbents can remove key drivers of inflammation and thrombosis, such as activated platelets and neutrophil extracellular traps (NETs). This approach may help treat thrombotic complications in sepsis and COVID-19.
Area of Science:
- Biomedical Engineering
- Immunology
- Hematology
Background:
- Inflammation and thrombosis are linked in critical illnesses like sepsis and COVID-19.
- Thrombotic complications indicate severe disease, leading to organ failure and death.
- Immunothrombosis involves the complement/tissue factor/neutrophil axis, activated platelets, and neutrophil extracellular traps (NETs).
Purpose of the Study:
- To investigate the potential of heparin-functionalized adsorbents in mitigating immunothrombosis.
- To evaluate the capacity of these adsorbents to deplete key effectors of immunothrombosis.
Main Methods:
- Utilized adsorbents functionalized with endpoint-attached heparin.
- Assessed the depletion of activated platelets, platelet-derived extracellular vesicles (pEVs), platelet factor 4 (PF4), high-mobility box 1 protein (HMGB1), histones, and nucleosomes.
Main Results:
- Heparin-functionalized adsorbents efficiently depleted activated platelets, pEVs, PF4, HMGB1, histones, and nucleosomes.
- These depleted factors are central effectors of deregulated immunothrombosis.
Conclusions:
- Heparin-functionalized adsorbents can eliminate key drivers of immunothrombosis.
- This depletion mechanism, rather than direct pathogen binding, may be clinically relevant for managing thrombosis in sepsis and COVID-19.
Abstract:
Inflammation and thrombosis are closely intertwined in numerous disorders, including ischemic events and sepsis, as well as coronavirus disease 2019 (COVID-19). Thrombotic complications are markers of disease severity in both sepsis and COVID-19 and are associated with multiorgan failure and increased mortality. Immunothrombosis is driven by the complement/tissue factor/neutrophil axis, as well as by activated platelets, which can trigger the release of neutrophil extracellular traps (NETs) and release further effectors of immunothrombosis, including platelet factor 4 (PF4/CXCL4) and high-mobility box 1 protein (HMGB1). Many of the central effectors of deregulated immunothrombosis, including activated platelets and platelet-derived extracellular vesicles (pEVs) expressing PF4, soluble PF4, HMGB1, histones, as well as histone-decorated NETs, are positively charged and thus bind to heparin. Here, we provide evidence that adsorbents functionalized with endpoint-attached heparin efficiently deplete activated platelets, pEVs, PF4, HMGB1 and histones/nucleosomes. We propose that this elimination of central effectors of immunothrombosis, rather than direct binding of pathogens, could be of clinical relevance for mitigating thrombotic complications in sepsis or COVID-19 using heparin-functionalized adsorbents.
More Related Videos
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Clot Retraction and Fibrinolysis
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

